Stocktoria
4D Molecular Therapeutics, Inc. FDMT
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-12-11
4D Molecular Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 4,896,897 | $102.8M | 8.45% |
| RENAISSANCE TECHNOLOGIES LLC | 578,265 | $5.4M | 1% |
| CITADEL ADVISORS LLC | 317,096 | $3.0M | 0.55% |
| TWO SIGMA INVESTMENTS, LP | 124,317 | $1.2M | 0.21% |
| AQR CAPITAL MANAGEMENT LLC | 45,777 | $426,183 | 0.08% |
| D. E. Shaw & Co., Inc. | 24,030 | $223,719 | 0.04% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.